ChemoMetec Financials
| CHY Stock | EUR 63.25 1.55 2.39% |
ChemoMetec |
Understanding current and past ChemoMetec Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ChemoMetec's financial statements are interrelated, with each one affecting the others. For example, an increase in ChemoMetec's assets may result in an increase in income on the income statement.
ChemoMetec Stock Summary
ChemoMetec competes with United Utilities, Universal Entertainment, Universal Insurance, AIR PRODCHEMICALS, and United Insurance. ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis in Denmark, the United States, Canada, rest of Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. CHEMOMETEC operates under Scientific Technical Instruments classification in Germany and is traded on Frankfurt Stock Exchange. It employs 147 people.| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | DK0060055861 |
| Business Address | Gydevang 43, Allerd, |
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Benchmark | Dow Jones Industrial |
| Website | chemometec.com |
| Phone | 45 48 13 10 20 |
| Currency | EUR - Euro |
You should never invest in ChemoMetec without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ChemoMetec Stock, because this is throwing your money away. Analyzing the key information contained in ChemoMetec's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ChemoMetec Key Financial Ratios
There are many critical financial ratios that ChemoMetec's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ChemoMetec AS reports annually and quarterly.ChemoMetec Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ChemoMetec's current stock value. Our valuation model uses many indicators to compare ChemoMetec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ChemoMetec competition to find correlations between indicators driving ChemoMetec's intrinsic value. More Info.ChemoMetec AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.64 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ChemoMetec AS is roughly 1.56 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ChemoMetec's earnings, one of the primary drivers of an investment's value.ChemoMetec AS Systematic Risk
ChemoMetec's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ChemoMetec volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on ChemoMetec AS correlated with the market. If Beta is less than 0 ChemoMetec generally moves in the opposite direction as compared to the market. If ChemoMetec Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ChemoMetec AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ChemoMetec is generally in the same direction as the market. If Beta > 1 ChemoMetec moves generally in the same direction as, but more than the movement of the benchmark.
ChemoMetec December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ChemoMetec help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ChemoMetec AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of ChemoMetec AS based on widely used predictive technical indicators. In general, we focus on analyzing ChemoMetec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ChemoMetec's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.7 | |||
| Information Ratio | 0.0866 | |||
| Maximum Drawdown | 39.0 | |||
| Value At Risk | (4.56) | |||
| Potential Upside | 6.14 |
Complementary Tools for ChemoMetec Stock analysis
When running ChemoMetec's price analysis, check to measure ChemoMetec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChemoMetec is operating at the current time. Most of ChemoMetec's value examination focuses on studying past and present price action to predict the probability of ChemoMetec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChemoMetec's price. Additionally, you may evaluate how the addition of ChemoMetec to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |